Cardiac myocytes may defend against the cytotoxicity of high-dose CY by expressing ALDH1, which plays a similar defensive role in donor regulatory T cells in PTCy [40], in cancer stem cells [41], and in hematopoietic stem cells [42]. The gene discussed is ALDH1A1; the disease is cancer.